In a recent study performed on primary cell cultures derived from PitNETs, metformin treatment inhibited cell viability in ACTH-secreting adenomas and non-functioning pituitary adenomas, but not prolactinomas, and in GH-secreting adenomas [89]. The gene discussed is POMC; the disease is pituitary gland adenoma.